C&EN White Paper
Cloud-based solutions: Enhancing AI-human interaction for faster drug discovery
Brought to you by Torx Software

Artificial intelligence (AI) has the potential to speed early stages of drug discovery. Yet harnessing its power requires optimizing how information from AI is transferred to researchers whose intuition is key to selecting drug candidates to move forward in a pipeline. Learn how software platforms for managing communications during drug discovery can be tools to create a pipeline centered on augmented intelligence, where AI enhances human decision making, rather than replaces it.

Key Objectives:
  • How harnessing the potential of AI for drug discovery depends on smoothing the interface between its output and researchers with medicinal chemistry intuition
  • See how cloud-based platforms support collaboration through smooth knowledge and data transfer during the design and make stages of drug discovery
  • Read a case study of augmented intelligence in action, where cloud-based software supported information transfer from AI to a global team of scientists

Brought to you by:
Torx Software
Please complete the form to download the white paper.
*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy